Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
about
Telomerase reverse transcriptase protects against Angiotensin II induced microvascular endothelial dysfunction.Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.
P2860
Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Friend or foe? Telomerase as a ...... er and cardiovascular disease.
@en
type
label
Friend or foe? Telomerase as a ...... er and cardiovascular disease.
@en
prefLabel
Friend or foe? Telomerase as a ...... er and cardiovascular disease.
@en
P2093
P2860
P1476
Friend or foe? Telomerase as a ...... er and cardiovascular disease.
@en
P2093
Andrew O Kadlec
Johnathan D Ebben
Karima Ait-Aissa
P2860
P304
P356
10.1016/J.PHRS.2016.07.003
P577
2016-07-06T00:00:00Z